Clinical Trials · NCT05530577

Effects of Semaglutide on Nicotine Intake

CompletedPhase 2Semaglutide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
University of North Carolina, Chapel Hill
Enrollment
24
Start date
Oct 2022
Locations
1 site, United States
Primary endpoint
Change in Nicotine Self-Administration
View Semaglutide compound reference